AIMS
To assess changes in glycated haemoglobin (HbA1c), body weight, and systolic/diastolic blood pressure (SBP/DBP) by chronic kidney disease (CKD) and albuminuria categories in a post hoc analysis of FLOW, an international, double-blind, randomized, phase 3b clinical trial of adults with CKD and Type 2 diabetes (T2D)...
A. Friedman, J. Basile, Robert S. Busch et al.· Diabetes, obesity and metabo...· 0 citations
INTRODUCTION
Once-weekly (OW) semaglutide has shown renal benefits in clinical trials for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). This study compared clinical outcomes between OW semaglutide and selected oral glucose-lowering medications in real-world settings.
METHODS
Adults with T2D an...
James Amamoo, Yan Wang, Hong-Jiao Liu et al.· Advances in Therapy· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.